Becker's ASC

Bausch + Lomb Receives FDA Approval of LOTEMAX Gel

Bausch + Lomb has announced it has received FDA approval of the company’s new drug application for LOTEMAX 0.5 percent gel drop formulation, according to a news release. The LOTEMAX (loteprednol ...
Business Insider

Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery

LOTEMAX SM Is Formulated with SubMicron Technology for Efficient Penetration To Key Ocular Tissues 1 BRIDGEWATER, N.J., Feb. 25, 2019 /CNW/ -- Bausch + Lomb, a leading global eye health company and ...
The American Journal of Managed Care

Review Finds Lotemax SM Safe to Use After Ocular Surgery

Loteprednol etabonate ophthalmic gel 0.38% (Lotemax SM) from Bausch & Lomb was found to have no meaningful impact on intraocular pressure or visual acuity when administered to patients post surgery, ...
Drug Store News

Lupin receives FDA approval for generic Lotemax

Lupin has received approval from the Food and Drug Administration for loteprednol etabonate ophthalmic gel, 0.38%, which is the generic of Bausch & Lomb’s Lotemax SM Ophthalmic Gel. Lupin is the ...